Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sushant Malhotra is active.

Publication


Featured researches published by Sushant Malhotra.


Bioorganic & Medicinal Chemistry Letters | 2003

Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles.

Thomas A. Engler; Kelly Wayne Furness; Sushant Malhotra; Concha Sanchez-Martinez; Chuan Shih; Walter Xie; Guoxin Zhu; Xun Zhou; Scott Eugene Conner; Margaret M. Faul; Kevin A. Sullivan; Stanley P. Kolis; Harold B. Brooks; Bharvin Patel; Richard M. Schultz; Tammy B. DeHahn; Kashif Kirmani; Charles D. Spencer; Scott A. Watkins; Eileen L. Considine; Jack Dempsey; Catherine A. Ogg; Nancy B. Stamm; Bryan D. Anderson; Robert M. Campbell; Vasu Vasudevan; Michelle L. Lytle

The synthesis and CDK inhibitory properties of a series of indolo[6,7-a]pyrrolo[3,4-c]carbazoles is reported. In addition to their potent CDK activity, the compounds display antiproliferative activity against two human cancer cell lines. These inhibitors also effect strong G1 arrest in these cell lines and inhibit Rb phosphorylation at Ser780 consistent with inhibition of cyclin D1/CDK4.


Tetrahedron Letters | 2003

An improved method for direct conversion of heteroaryl-aldehydes to heteroaryl-acetonitriles

Thomas A. Engler; Kelly Wayne Furness; Sushant Malhotra; Clive Gideon Diefenbacher; Joshua Ryan Clayton

Abstract Treatment of heteroaryl-aldehydes with diethyl cyanophosphonate in the presence of a catalytic amount of LiCN affords phosphorylated cyanohydrins which are reduced in situ with SmI 2 to give heteroaryl-acetonitriles in generally good overall yields (50–100%). The generality of the process is demonstrated.


Journal of Medicinal Chemistry | 2004

Substituted 3-Imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino- [6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as Highly Selective and Potent Inhibitors of Glycogen Synthase Kinase-3

Thomas A. Engler; James Robert Henry; Sushant Malhotra; Brian Eugene Cunningham; Kelly Wayne Furness; Joseph T. Brozinick; Timothy Paul Burkholder; Michael P. Clay; Joshua Ryan Clayton; Clive Gideon Diefenbacher; Eric Hawkins; Philip W. Iversen; Yihong Li; Terry D. Lindstrom; Angela Lynn Marquart; Johnathan Alexander Mclean; David Mendel; Elizabeth A. Misener; Daniel A. Briere; John O'Toole; Warren J. Porter; Steven Queener; Jon K. Reel; Rebecca A. Owens; Richard A. Brier; Thomas E. Eessalu; Jill R. Wagner; and Robert M. Campbell; Renee Vaughn


Bioorganic & Medicinal Chemistry Letters | 2005

The development of potent and selective bisarylmaleimide GSK3 inhibitors.

Thomas A. Engler; Sushant Malhotra; Timothy Paul Burkholder; James Robert Henry; David Mendel; Warren J. Porter; Kelly Wayne Furness; Clive Gideon Diefenbacher; Angela Lynn Marquart; Jon K. Reel; Yihong Li; Joshua Ryan Clayton; Brian Eugene Cunningham; Johnathan Alexander Mclean; John C. O’Toole; Joseph T. Brozinick; Eric Hawkins; Elizabeth A. Misener; Daniel A. Briere; Richard A. Brier; Jill R. Wagner; Robert M. Campbell; Bryan D. Anderson; Renee Vaughn; Donald B. Bennett; Timothy I. Meier; James A. Cook


Archive | 2003

Purine derivatives as kinase inhibitors

Brian R. Berridge; Joshua Ryan Clayton; Clive Gideon Diefenbacher; Thomas A. Engler; Kelly Wayne Furness; James Robert Henry; Sushant Malhotra; Angela Lynn Marquart; Johnathan Alexander Mclean; David Mendel; Timothy Paul Burkholder; Yihong Li; Jon K. Reel; Charles Edward Ruegg; John M. Sullivan


Archive | 2005

Tgf-beta inhibitors

Clive Gideon Diefenbacher; Thomas A. Engler; Hong-Yu Li; Sushant Malhotra; Jason Scott Sawyer; Yan Wang


Archive | 2003

Pyrrole-2, 5-dione derivatives and their use as gsk-3 inhibitors

Pamela Ann Albaugh; Jochen Ammenn; Timothy Paul Burkholder; Joshua Ryan Clayton; Scott Eugene Conner; Brian Eugene Cunningham; Thomas A. Engler; Kelly Wayne Furness; James Robert Henry; Yihong Li; Sushant Malhotra; Mark Joseph Tebbe; Guoxin Zhu


Archive | 2003

Novel compounds as pharmaceutical agents

Douglas Wade Beight; Timothy Paul Burkholder; Todd Vincent Decollo; Alexander Glenn Godfrey; Charles Raymond Heap; Chi-Hsin Richard King; Hong-Yu Li; William Thomas Mcmillen; Jason Scott Sawyer; Yan Wang; Clive Gideon Diefenbacher; Thomas A. Engler; Sushant Malhotra; Sreenivasa Reedy Mundla


Archive | 2001

Methods and compounds for treating proliferative diseases

Thomas A. Engler; Kelly Wayne Furness; Sushant Malhotra; Stephen L. Briggs; Harold B. Brooks; David K. Clawson; Concepcion Sanchez-Martinez; Faming Zhang; Guoxin Zhu


Archive | 2003

Compounds as pharmaceutical agents

Douglas Wade Beight; Timothy Paul Burkholder; Todd Vincent Decollo; Alexander Glenn Godfrey; Charles Raymond Heap; Chi-Hsin Richard King; Hong-Yu Li; William Thomas Mcmillen; Jason Scott Sawyer; Yan Wang; Clive Gideon Diefenbacher; Thomas A. Engler; Sushant Malhotra; Sreenivasa Reedy Mundla

Collaboration


Dive into the Sushant Malhotra's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yihong Li

Eli Lilly and Company

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge